Audrey Wall

Dr. Audrey Wall

Nuritas Limited
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2021 in Frontiers in Genetics
Verified
Journal Article
Open access
ADAoife Doherty
Aoife Doherty
Audrey WallAudrey Wall
Audrey Wall
NKNora Khaldi
Nora Khaldi
Martin KussmannMartin Kussmann
Martin Kussmann
Scientific research consistently demonstrates that diseases may be delayed, treated, or even prevented and, thereby, health may be maintained with health-promoting functional food ingredients (FFIs). Consumers are increasingly demanding sound information about food, nutrition, nutrients, and their associated health benefits. Consequently, a nutrition industry is being formed around natural foods and FFIs, the economic growth of which is increasingly driven by consumer decisions. Information technology, in particular artificial intelligence (AI), is primed to vastly expand the pool of characterised and annotated FFIs available to consumers, by systematically discovering and characterising natural, efficacious, and safe bioactive ingredients (bioactives) that address specific health needs. However, FFI-producing companies are lagging in adopting AI technology for their ingredient development pipelines for several reasons, resulting in a lack of efficient means for large-scale and high-throughput molecular and functional ingredient characterisation. The arrival of the AI-led technological revolution allows for the comprehensive characterisation and understanding of the universe of FFI molecules, enabling the mining of the food and natural product space in an unprecedented manner. In turn, this expansion of bioactives dramatically increases the repertoire of FFIs available to the consumer, ultimately resulting in bioactives being specifically developed to target unmet health needs.

1 February 2014 in Neurobiology of Disease
Verified
Journal Article
Closed access
Audrey WallAudrey Wall
Audrey Wall
ACAlan E. Corcoran
Alan E. Corcoran
KOKen D. O'Halloran
Ken D. O'Halloran
JOJohn O'connor
John O'connor

12 January 2015 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
Audrey WallAudrey Wall
Audrey Wall
GMGatambwa Mukandala
Gatambwa Mukandala
NGNigel H. Greig
Nigel H. Greig
JOJohn O'connor
John O'connor

26 May 2020 in International Journal of Cosmetic Science
Verified
Journal Article
Closed access
PDF file
Kathy KennedyKathy Kennedy
Kathy Kennedy
RCRoi Cal
Roi Cal
RCRory Casey
Rory Casey
CLCyril Lopez
Cyril Lopez
AAAlessandro Adelfio
Alessandro Adelfio
NKNora Khaldi
Nora Khaldi

1 January 2021 in Current Research in Food Science
Verified
Journal Article
Open access
ACAlberto R. Corrochano
Alberto R. Corrochano
RCRoi Cal
Roi Cal
Kathy KennedyKathy Kennedy
Kathy Kennedy
Audrey WallAudrey Wall
Audrey Wall
NMNiall Murphy
Niall Murphy
NKNora Khaldi
Nora Khaldi
Characterising key components within functional ingredients as well as assessing efficacy and bioavailability is an important step in validating nutritional interventions. Machine learning can assess large and complex data sets, such as proteomic data from plants sources, and so offers a prime opportunity to predict key bioactive components within a larger matrix. Using machine learning, we identified two potentially bioactive peptides within a Vicia faba derived hydrolysate, NPN_1, an ingredient which was previously identified for preventing muscle loss in a murine disuse model. We investigated the predicted efficacy of these peptides in vitro and observed that HLPSYSPSPQ and TIKIPAGT were capable of increasing protein synthesis and reducing TNF-α secretion, respectively. Following confirmation of efficacy, we assessed bioavailability and stability of these predicted peptides and found that as part of NPN_1, both HLPSYSPSPQ and TIKIPAGT survived upper gut digestion, were transported across the intestinal barrier and exhibited notable stability in human plasma. This work is a first step in utilising machine learning to untangle the complex nature of functional ingredients to predict active components, followed by subsequent assessment of their efficacy, bioavailability and human plasma stability in an effort to assist in the characterisation of nutritional interventions.

13 May 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Sweeny ChauhanSweeny Chauhan
Sweeny Chauhan
AKAlish Kerr
Alish Kerr
BKBrian Keogh
Brian Keogh
SNStephanie Nolan
Stephanie Nolan
RCRory Casey
Rory Casey
NKNora Khaldi
Nora Khaldi
The prevalence of prediabetes is rapidly increasing, and this can lead to an increased risk for individuals to develop type 2 diabetes and associated diseases. Therefore, it is necessary to develop nutritional strategies to maintain healthy glucose levels and prevent glucose metabolism dysregulation in the general population. Functional ingredients offer great potential for the prevention of various health conditions, including blood glucose regulation, in a cost-effective manner. Using an artificial intelligence (AI) approach, a functional ingredient, NRT_N0G5IJ, was predicted and produced from Pisum sativum (pea) protein by hydrolysis and then validated. Treatment of human skeletal muscle cells with NRT_N0G5IJ significantly increased glucose uptake, indicating efficacy of this ingredient in vitro. When db/db diabetic mice were treated with NRT_N0G5IJ, we observed a significant reduction in glycated haemoglobin (HbA1c) levels and a concomitant benefit on fasting glucose. A pilot double-blinded, placebo controlled human trial in a population of healthy individuals with elevated HbA1c (5.6% to 6.4%) showed that HbA1c percentage was significantly reduced when NRT_N0G5IJ was supplemented in the diet over a 12-week period. Here, we provide evidence of an AI approach to discovery and demonstrate that a functional ingredient identified using this technology could be used as a supplement to maintain healthy glucose regulation.